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Abstract
Introduction: Coronary artery aneurysm is an uncommon disease. It is defined as a coronary artery dilatation,
exceeding the diameter of the normal adjacent segment or the diameter of the patient’s largest coronary vessel by
1.5 to 2 times. Coronary artery aneurysms are typically diagnosed by coronary angiography. The prognosis of
coronary artery aneurysm is not well known and the management is challenging.
Case presentation: A 68-year-old Italian-Caucasian man presented to our hospital with angina. Coronary
angiography revealed a large coronary aneurysm of the right coronary artery, which was successfully treated by
the percutaneous implantation of an MGuard™stent.
Conclusion: This case report provides evidence that coronary artery aneurysms, even if very large, can be safely
treated by MGuard™stent implantation. We strongly emphasize the high flexibility and good deliverability of this
device, which leads to the complete exclusion of the aneurysm mediated by the process of endothelization of its
thin mesh sleeves.
Introduction
Coronary artery aneurysm is a rare disorder character-
ized by an abnormal dilatation (diameter >50% of the
normal adjacent segments) of a localized or diffuse por-
tion of the coronary artery [1,2]. The detected incidence
on angiography varies from 0.3% to 4.9% in large studies
[1,2]. Atherosclerosis is the most common etiology esti-
mated at 50% of cases diagnosed in adults; independent
of the etiology, the aneurysmal segment produces turbu-
lent blood flow with an increased incidence of myocar-
dial ischemic manifestations (acute coronary syndromes,
thromboembolism, rupture or vasospasm) [3-5]. The
indication for treatment and the best modalities still
need to be defined [6]. In recent years different studies
have reported the treatment of coronary aneurysm with
the polytetrafluoroethylene (PTFE) covered stents as a
valuable alternative to surgery in selected cases (dia-
meter six to 10mm) [7,8]. However, the use of this
device is limited by its dimension, by the low flexibility
(that makes implantation very difficult in tortuous ves-
sels), by the lack of access of side branches and by the
inherent risk of restenosis. The MGuard™stent (Inspir-
eMD Ltd, Tel Aviv, Israel) is a novel coronary device
composed of a multicellular stainless steel stent with an
integrated polyethylene terephthalate (PET) protective
sleeve mesh (15 μm single PET knit fiber with 150 μm
×1 5 0μm apertures) (Figure 1a). The sleeve acts as a
snowshoe, averaging the expansion impact while pre-
venting embolic dislodgment. This stent has a high flex-
ibility and a low profile that can challenge very complex
anatomies; the process of endothelization of this device
transforms the mesh sleeve into a membrane that has
the potential to seal coronary aneurysms [9,10].
Case presentation
A 68-year-old Italian-Caucasian man who had a pre-
vious angioplasty to an obtuse marginal branch pre-
sented to our institution for angina and a positive
myocardial perfusion imaging test (reversible perfusion
defects on inferior wall). An angiography showed a
patent stent on obtuse marginal artery and a large cor-
onary aneurysm of the right coronary artery (6.7 mm in
diameter and 15.2 mm in length) (Figure 1b; additional
file 1)[1,2]. A 3.5 to 24 mm long MGuard™stent was
implanted, using a pressure of 16 bar (additional file 2).
After stent deployment, the injection of dye showed par-
tial opacification of the aneurysmal sac through the
holes of the net, with some stagnation of blood (Figure
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Figure 1 Coronary angiography and CT scan before and after MGuard stent implantaion. (A) The unexpanded (top) and the expanded
stent covered with a sleeve mesh (bottom). Reproduced with permission from InspireMD. (B) Angiography of the right coronary artery with the
presence of a large saccular aneurysm involving the distal part of the artery to the crux cordis. (C) Partial opacification of the aneurysmal sac
through the holes of the mesh just after stent implantation. (D) Coronary angiography at one month follow-up showing the exclusion of the
aneurysm. (E) Coronary CT scan at one month: multiplanar reformation of the right coronary artery near the crux cordis; on the right ventricle
side of the distal part of the stent, is clearly demonstrated the water density remnant of the treated aneurysm (arrows): low density fat is
surrounding the proximal stent. (F) Coronary CT scan at one month: The magnified view of the stent allows for a better identification of the
treated aneurysm (arrows).
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Page 2 of 41c; additional file 3). His hospital stay was uneventful
and our patient was discharged the day after the proce-
dure with dual anti-platelet therapy. At one month our
patient was totally asymptomatic. The coronary com-
puted tomography (CT) scan showed a good stent appo-
sition (Figure 1e,f) with complete exclusion of the
aneurysm that was also confirmed by angiography (Fig-
ure 1d; additional file 4).
Conclusions
Coronary artery aneurysms may be complicated by
thrombosis and rupture. The optimal treatment
options of coronary aneurysms are still largely debated.
They include anticoagulation, covered stents, recon-
struction, resection and exclusion with bypass [11].
The PTFE-covered stents have been used to treat cor-
onary artery aneurysms, but the restenosis rate and
long-term effectiveness of covered stents are unknown.
The newly developed balloon-expandable MGuard™s-
tent system with its combination of an ultra-thin poly-
mer mesh sleeve attached to the external of a bare
metal stent surface has been designed to provide
embolic protection during percutaneous coronary
intervention restenosis by bare metal stents, peripheral
embolism following stent implantation in vein grafts,
and conditions in which there is a discontinuity of the
coronary lumen (rupture or perforation, aneurysm, and
fistula). This device demonstrated excellent perfor-
mance in a highly complex lesion subset such as cover
coronary artery perforations or arteriovenous fistulas
with high success and acceptable rates of acute compli-
cations. Based on its technical features, we decided to
use the MGuard™stent to seal a coronary artery aneur-
ysm. This experience suggests a new potential indica-
tion for the use of MGuard™coronary stent as an
attractive alternative treatment with less risk of in-
stent restenosis. In human coronary arteries the com-
plete exclusion of the aneurysmal sac (that is mediated
by the process of endothelization of the ultra-thin PET
mesh sleeve) is not immediate and seems to require at
least four weeks. The high flexibility and the good deli-
verability make the MGuard™device an attractive alter-
native to the currently available covered stent for an
effective treatment of coronary aneurysm.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Additional material
Additional file 1: Coronary angiography showing a large coronary
artery aneurysm. Right anterior oblique view of the right coronary
artery with the presence of a large aneurysm involving the distal part of
the artery till the crux cordis.
Additional file 2: MGuard stent implantation. Stent deployment at a
pressure of 16 bar.
Additional file 3: Coronary angiography after stent implantation.
Opacification of the aneurysmal sac through the holes of the net, with
some stagnation of blood.
Additional file 4: Coronary angiography at one month follow up.
Follow-up angiography at one month showing the complete exclusion
of the aneurysmal sac.
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